“Sam is an older brother for me, he’s really like family,” said Frech, who cleared 1.80 on Tuesday but failed to win a medal.
AMARILLO, Texas (KAMR/KCIT) — Officials with Amarillo Family Eyecare announced Tuesday it will be providing free eye exams and glasses for children, ages 17 and younger, without vision insurance at 8:30 a.m. Sept. 11 at its location at 2921 I-40 Frontage Rd. This event will be hosted through the Essilor Vision Foundation Changing Life Through Lenses program, a news release states. This program provides lenses and lab services at no cost for participants on a first-come, first-served basis. “We know there are children in our community who lack access to much needed vision care,” Mackenzie Weir, an optometrist with Amarillo Family Eyecare, said in the release. “We can make a significant impact in our community and demonstrate our commitment to helping children see clearly by participating in the Changing Life through Lenses program.” Kim Schuy, the president of the Essilor Vision Foundation, said in the release that the foundation has given more than 500,000 pairs of glasses through its efforts across the United States. “It is thanks to partnerships with offices like Amarillo Family Care that we are able to provide children the tools they need to succeed in school and life,” she said in the release. The post Amarillo Family Eyecare to host free vision services for eligible children | KAMR appeared first on Medical News And Updates.
0 Comments
Frech is 16 and the youngest member of the American Paralympic track and field team. “I watched Sam compete in Rio, and I realized that’s what I want to do with my life,” Frech added. Grewe said Frech would call him almost daily and send videos of his jumping technique. Grewe could empathize easily, already filling a spot as coach, role model, and caregiver. “I think there are so many lessons that can’t be learned in a textbook for doctors,” Grewe said. “Things like compassion, empathy, taking a holistic approach when you’re working with a patient.” Grewe said a man in Tokyo encountered him recently as he was walking to the track and handed him a note. It explained that his 10-year-old son had been diagnosed with the same bone cancer that Grewe had, and also went ahead with the choice of losing his leg. Grewe said the man had seen him jump, which offered assurance that his son would also recover and have a full sporting life. He said the young boy was now playing soccer in middle school, a moment he said that brought him back “full circle” the the young boy he once was. “I wouldn’t wish any of my peers to go and get cancer so they could experience what it’s like to be a patient,” Grewe said. “But I learned so much during my time as a patient. It almost felt irresponsible to not go out and give back those lessons to people like me who are going through similar experiences.” The post Jumper Sam Grewe wins gold and now heads of medical school | Sports appeared first on Medical News And Updates. US coronavirus: These 5 states have less than 10% of ICU beds left as Covid-19 overwhelms hospitals8/31/2021 In Georgia, the CEO of Northeast Georgia Health Systems said it had 287 Covid patients Monday morning, which is more than the hospital has had since January. “So, in essence, our hospitals are full,” Carol Burrell said. “We’re looking to add space in hallways and conference rooms in waiting areas. Our emergency rooms and our urgent care centers are seeing higher volume than they’ve seen throughout this pandemic,” she said. Hospitals around the country have been stretched as cases have picked back up, but the South, where vaccinations have been lagging, has been particularly hit. Many hospitals have been reporting oxygen shortages. On Monday, data presented by a vaccine adviser from the US Centers for Disease Control and Prevention showed a hospitalization rate 16 times greater in the unvaccinated population than in those vaccinated. “This to me seems to be a strong indication that the current epidemiologic curve that we’re seeing is really a reflection of failure to vaccinate, not vaccine failure,” said Dr. Matthew F. Daley at the CDC Advisory Committee on Immunization Practices meeting. The effect of the low vaccination levels can be seen in Kentucky, where hospitals are overwhelmed with record numbers of Covid-19 patients and 58 of the 96 hospitals are reporting critical staffing shortages, Gov. Andy Beshear said Monday. “We’re living in a reality where some Covid patients who are sick are being treated in their cars when there isn’t room for them inside the ER or inside the hospital,” Beshear said. And Mississippi is also struggling, with only nine ICU beds available in the state, Mississippi Department of Health Senior Deputy and Director Jim Craig said Monday. With increased hospitalizations, more deaths have followed. The Central Florida Disaster Medical Coalition has purchased a total of 14 portable morgues to help with the “unprecedented” number of Covid-19 deaths in the region, the organization told CNN. The number of rising cases has also been seen in children, with the number of children testing positive for Covid-19 earlier this month reaching levels not seen since last winter, according to the American Academy of Pediatrics. The rise in children’s infections is worrying experts as parents and students prepare for a new school year. Thousands of students in quarantineHealth experts have been particularly concerned about how cases will trend as school gets underway; and with many regions early in their academic year, thousands of students are already back in quarantine. In Florida’s 15 largest school districts, at least 21,869 students and 4,481 employees have tested positive for Covid-19 since the start of school, according to a CNN analysis. At least another 45,024 students and staff members have been quarantined or put on “stay home” directives due to possible exposure to Covid-19. That’s an increase of 62% since CNN’s last update on Thursday afternoon. In Texas, after just the first two weeks of school in the Fort Worth Independent School District, more than 3,000 students have been quarantined due to close contact with individuals who tested positive for Covid-19. The district announced a mask mandate earlier this month for all students, employees and guests, despite ongoing legal battles in the state against Gov. Greg Abbott’s ban on such mandates. While vaccines are currently the best defense against the spread of the virus, they have not yet been approved for those under the age of 12.
But not even those children who are eligible for the protection are not reaping the full benefits. Children ages 12 to 15 are eligible but less then half of that group is vaccinated with at least one dose, according to data published Monday by the CDC.
School infections could be cut in half by masking and testing, projections showWhile the risk of unvaccinated students becoming infected when they go to school is of concern, a new study shows that masking and testing could help prevent infections in at least half of that population. With universal mask use, less than half of susceptible students — and perhaps as few as a quarter — may become infected with Covid-19 in the same timeframe, depending on the student body’s incoming level of protection from vaccinations or natural immunity, according to , projections modeled by researchers from North Carolina State University and published as a preprint earlier this month. Adding randomized testing for half of the students biweekly, and assuming at least a 70% compliance with isolation requirements for those who test positive, would cut Covid-19 infections down to less than a quarter of all susceptible students in all scenarios, the researchers’ projections suggested. The model assumes that in a class of 500, two or three students are infected at the start of the school year and that one additional case enters the school each week. Dr. Scott Gottlieb, former commissioner of the US Food and Drug Administration told CBS’s Ed O’Keefe on Sunday that “we have to throw everything we can” at minimizing cases among school children. “I don’t think that we should be going into the school year lifting the mitigation that may have worked and probably did work last year to control outbreaks in the school setting, until we have firm evidence on what works and what doesn’t,” he said, adding measures such as frequent testing and putting students in social pods “are probably the two most effective steps schools can be taking.” CNN’s Angela Barajas, Kiely Westhoff, Taylor Romine, Elizabeth Joseph, Mallory Simon, Elizabeth Stuart and Deidre McPhillips contributed to this report. The post US coronavirus: These 5 states have less than 10% of ICU beds left as Covid-19 overwhelms hospitals appeared first on Medical News And Updates.
PANAMA CITY, Aug 30 (Reuters) – Panama’s national assembly unanimously passed a bill on Monday that would regulate the use of medical cannabis, making it the first nation in Central American to do so. The proposal, which would set up a registry of authorized cannabis patients and permit further research on the drug, was approved by a vote of 44 lawmakers in favor and none voting against it. Assembly President Crispiano Adames hailed the bill as “innovative,” citing multiple ailments that can be treated with cannabis once the proposal becomes law. The bill now awaits the signature of President Laurentino Cortizo. Reporting by Elida Moreno; Editing by David Alire Garcia and Kim Coghill Our Standards: The Thomson Reuters Trust Principles. The post Panama’s Congress approves medical cannabis bill in unanimous vote appeared first on Medical News And Updates. Whether scrolling on social media, reading a work report on our laptop, or even watching TV, it is safe to say that many of us spend a lot of time glued to our electronic devices. But did you know, that all of that blue light shining from the screens can end up damaging your eyesight? To find out more about the risks of blue light exposure, we had a chat with Dr. Arjun Malla Bhari, Senior Consultant Ophthalmologist at EyeCare Hospital. What is blue light?“Blue light is part of the visible light spectrum, what the human eye can see,” Dr. Arjun explains. “While visible light contains a range of wavelengths and energy, blue light has very short, high energy waves. Due to its high energy, blue light has more potential to cause harm to the eye than other visible light. While sunlight is the most significant source of blue light, artificial sources include fluorescent lights, ‘energy saving’ bulbs, digital billboards, LED televisions, computer monitors, smart phones and tablet screens. Blue light does have certain health benefits. It boosts alertness, helps memory and cognitive function, and elevates mood. It also regulates the circadian rhythm, the body’s natural wake and sleep cycle. However, there is concern about the long-term effects of screen exposure, especially with excessive screen time and when a screen is too close to the eyes Why is blue light harmful to our eyesight?Blue light has various negative effects on our eyesight. Though further research is necessary to determine whether it directly impacts our eyesight, Dr. Arjun notes that there are both shortterm and long-term risks of prolonged blue light exposure that we already know of. The most common problem caused by blue light exposure is eye strain, which can result in dry eyes, fatigue, and headaches. Furthermore, there are concerns that continued exposure to blue light over time may cause vision problems such as age-related macular degeneration, although Dr. Arjun states that more research is necessary in this regard. However, based on studies conducted on animals, continued blue light exposure has often been linked to various health problems, both physical and mental. “As a result of the COVID-19 pandemic, as people spend more time on their screens, these problems have been further aggravated,” Dr. Arjun adds. “This is especially true of children and those with existing eyesight problems.” How can we reduce the negative impacts of blue light?In this digital day and age, although we are exposed to blue light both indoors and outdoors, we can limit the negative effects it may have on our eyesight by simply changing our habits and looking out for our health. One of the most important effective things we can do is to limit our screen time. If you have to use your electronic devices for prolonged periods such as for work or school, make sure to take breaks away from the screen every half hour to give your retinas a rest. Additionally, when picking out bulbs to use at night time, choose ones that emit more red-light wavelengths. Another tip is to try to limit your time watching TV, and if using a smartphone or other devices, turn on their blue light filters. Blue light glasses may also be helpful if you have trouble falling asleep. EyeCare Opticals, the leading eye care service provider in the Maldives, offers blue light glasses as well as consultations with specialists who can help alleviate your concerns. For more information, visit https://eyecare.mv/ The post The Dark Side of Blue Light – How Does It Harm Our Eyesight? appeared first on Medical News And Updates.
Work to remove the New Deal-era frescoes depicting the “History of Medicine in California” from the UCSF medical school Parnassus campus has been temporarily halted by court order. The motion for a restraining order, requested by San Franciscans for Balanced and Livable Communities in a bid to stop construction of a new hospital complex, was granted by Alameda County Superior Court Judge Frank Roesch. It prohibits any “construction or demolition activities … that relate to the execution of plans to remove the … murals from their present location in UCSF Toland Hall until a preliminary injunction hearing can be held on Sept. 16,” read the decision by Roesch. The restraining order put an immediate stop to a $3.2 million project begun in January to remove and store the 10-panel fresco painted in 1938 by Bernard Zakheim. The panels are located inside a medical school building, Toland Hall, which was deemed seismically unsafe and is scheduled for demolition next year. The skylight has been lifted off Toland Hall to create an opening large enough to extricate the panels by crane. Work was underway to cut the murals out of the wall in preparation to be airlifted. That project was suspended by the court order, and the skylight opening covered by plywood. According to UCSF spokesperson Kristen Bole, the murals themselves have three layers of protection. Descendants of the artist and the head of the conservation firm hired to remove the art fear that protection is insufficient. “It exposes the murals to the range of elements and that is very disheartening thing for my family to hear,” Adam Gottstein, grandson of the artist Zakheim and family spokesperson, said. The family was not a plaintiff in the suit but generally supports efforts to keep the murals where they are, Gottstein said. A delay in the removal project may cause “irreparable harm to the murals,” said David Wessel, principal of Architectural Resources Group Conservation Services. As a witness opposed to the restraining order, Wessel noted that the project will now have to be postponed until spring, 2022, after the rainy season. He said water from building leaks already has damaged the murals. The climate-control system in the building has been removed, putting the art at further risk, Bole said. The delay, with a crane already on-site, is expected to cost an additional $200,000 and that number will rise if the roof requires a more permanent solution to get through the winter. The motion to save the murals is part of a larger strategy to stop expansion and redevelopment of the UCSF campus in Parnassus Heights. In February, three neighborhood organizations — San Franciscans for Balanced and Livable Communities, the Parnassus Neighborhood Coalition, and Yerba Buena Neighborhood Consortium — each sued to overturn the Board of Regents decision to allow construction of a 2 million-square-foot hospital and medical center in the already dense Parnassus Heights neighborhood, to the south of Kezar Stadium in Golden Gate Park. The removal of the murals is “the tip of the spear,” said Patrick Soluri, attorney for the Parnassus Neighborhood Coalition. “The only aspect of the project that is going forward was the removal of the Zakheim murals,” Soluri told The Chronicle. The court order “stops construction and preserves the status quo until the preliminary injunction can be ruled upon.” UCSF said it would abide by the judge’s order to halt the mural removal. But the administration disputes that this order stops the plan to demolish Toland Hall and replace it with a new hospital. It was “inaccurate and misleading to claim that the temporary order applies to anything other than the temporary suspension of work on removing the murals until the Alameda Court can review the PNC’s request against the facts,” Bole said. Sam Whiting is a San Francisco Chronicle staff writer. Email: [email protected] Twitter: @SamWhitingSF The post New Deal-era murals at UCSF med school to stay in place, judge rules appeared first on Medical News And Updates. For the past week, Dr. Gregory Yu, an emergency physician in San Antonio, has received the same daily requests from his patients, some vaccinated for Covid-19 and others unvaccinated: They ask him for ivermectin, a drug typically used to treat parasitic worms that has repeatedly failed in clinical trials to help people infected with the coronavirus. Dr. Yu has refused the ivermectin requests, he said, but he knows some of his colleagues have not. Prescriptions for ivermectin have seen a sharp rise in recent weeks, jumping to more than 88,000 per week in mid-August from a prepandemic baseline average of 3,600 per week, according to researchers from the Centers for Disease Control and Prevention. Some pharmacists are even reporting shortages of the drug. Travis Walthall, a pharmacist in Kuna, Idaho, a town of about 20,000 people, said that this summer alone he had filled more than 20 ivermectin prescriptions, up from two or three in a typical year. For the past week he has not been able to obtain the drug from his suppliers; they were all out. Mr. Walthall was astonished, he said, at how many people were willing to take an unapproved drug for Covid. “I’m like, gosh, this is horrible,” he said. While sometimes given to humans in small doses for head lice, scabies and other parasites, ivermectin is more commonly used in animals. Physicians are raising alarms about a growing number of people getting the drug from livestock supply centers, where it can come in highly concentrated paste or liquid forms. Calls to poison control centers about ivermectin exposures have risen dramatically, jumping fivefold over their baseline in July, according to C.D.C. researchers, who cited data from the American Association of Poison Control Centers. Mississippi’s health department said earlier this month that 70 percent of recent calls to the state poison control center had come from people who ingested ivermectin from livestock supply stores. Dr. Shawn Varney, a toxicologist and medical director for the South Texas Poison Center, said that in 2019 his center received 191 calls about exposure to ivermectin; so far this year the center has received 260 calls and is on pace to reach 390 by the end of the year. The vast majority of the recent calls came from people who took a veterinary product in an attempt to treat or prevent Covid-19. “Everyone wants some cure for Covid because it’s such a devastating illness,” Dr. Varney said. “I plead with people to stop using ivermectin and get the vaccine because it’s the best protection we have at this point. Everything else is risk after risk.” Dr. Varney said people calling the poison control center after taking ivermectin sometimes reported nausea, muscle pain and diarrhea. He noted that there have been ivermectin overdose deaths in the past, though he did not know of any specifically associated with Covid-19. The biggest risk, he added, comes from people taking the livestock product and ingesting a far higher dose than is appropriate for humans — sometimes 10 to 15 times the amount that a capsule approved for humans might contain. “People are going to animal feed stores and getting a formulation that’s highly concentrated because it’s for 1,000-pound animals,” Dr. Varney said. “They’re opening themselves to great potential harm.” Ivermectin was introduced as a veterinary drug in the late 1970s, and the discovery of its effectiveness in combating certain parasitic diseases in humans won the 2015 Nobel Prize for medicine. Though it has not been shown to be effective in treating Covid, people are now clamoring to get the drug, trading tips in Facebook groups and on Reddit. Some physicians have compared the phenomenon to last year’s surge of interest in hydroxychloroquine, though there are more clinical trials evaluating ivermectin. The Food and Drug Administration weighed in last week. “You are not a horse,” the agency tweeted, with a warning explaining that ivermectin is not F.D.A.-approved for treating or preventing Covid-19 and that taking large doses can cause serious harm. A recent review of 14 ivermectin studies, with more than 1,600 participants, concluded that none provided evidence of the drug’s ability to prevent Covid, improve patient conditions or reduce mortality. Another 31 studies are still underway to test the drug. “There is great interest in repurposing well-known inexpensive drugs such as ivermectin that are readily available as an oral tablet,” Maria-Inti Metzendorf and Stephanie Weibel, the authors of the review, said in an email to The Times. “Even if these circumstances seem ideal, the results from the available clinical studies carried out so far cannot confirm the widely advertised benefits.” One of the largest trials studying ivermectin for Covid-19 treatment, called the Together Trial, was halted by the data safety monitoring board on Aug. 6 because the drug had been shown to be no better than a placebo at preventing hospitalization or prolonged stay in the emergency room. Dr. Edward Mills, a professor at McMaster University who led the study, which enrolled more than 1,300 patients, said the team would have discontinued it earlier were it not for the level of public interest in ivermectin. “The data safety person said, ‘This is now futile and you’re offering no benefit to patients involved in the trial,’” Dr. Mills said. Another study of the drug found that ivermectin could be fairly benign unless taken at high doses. Dr. Eduardo López-Medina, a researcher at the Center for Pediatric Infectious Diseases in Colombia, led a randomized control trial for the study last spring on the effects of ivermectin and found that it had no statistically significant effect on reducing the duration of Covid symptoms. But he also found that there was no statistically significant increase in adverse events for the patients receiving ivermectin, though they were taking a fairly high dose of 300 micrograms per kilogram. “It appears to be a safe medication, but that is not enough to prescribe it openly,” Dr. López-Medina said. “People should use it in trials but not necessarily to treat patients. The data is not robust enough to support its use.” Researchers and physicians are particularly alarmed by people seeking out ivermectin as a form of possible prevention or treatment instead of getting one of the highly effective Covid vaccines. The F.D.A. fully approved the Pfizer-BioNTech Covid vaccine for people 16 and older last week, and an approval of Moderna’s vaccine is expected in the coming weeks. “The only functional strategy we have for getting control of Covid-19 is vaccination,” said Dr. Irwin Redlener, a physician in New York and founding director of the National Center for Disaster Preparedness at Columbia University. “If people are not getting vaccinated because of nonsense they’re reading on the internet, that interferes with our ability to get this pandemic under control.” The post Ivermectin Demand Surges Though It Doesn’t Work for Covid-19 appeared first on Medical News And Updates. The Major Medical Expenses (GMM) policy is designed to cover the payment for reimbursement of important illnesses that require expensive treatments. Fortunately, there is already better knowledge of diseases and how to prevent them, for them it is important that you know the insurance you need to take out. Today, given the great variety of offer that exists to contract medical expenses insurance and in the face of the number of companies that compete for this market, it is difficult to choose one. For this reason, it is essential, before making a decision, to know what types of insurance are offered and what is the detail of the service that the companies contemplate. Here we will give you some tips to help you make a better decision: 1. Decide the type of policy you want to contract 2. Do you offer benefits or coverage for dental treatments? 3. Are your rates differentiated according to criteria of age, sex and socioeconomic profile? 4. Check how the company acts in case of frequent use of medical services 5. Check the coverage that the company offers Copyright 2021 Entrepreneur.com Inc., All rights reserved The post How to choose major medical insurance? appeared first on Medical News And Updates. Dublin, Aug. 30, 2021 (GLOBE NEWSWIRE) — The “Contract Research Outsourcing – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. CRO Market Slumps by -1.9% in 2020 Only to Emerge Stronger With Newer Dynamics in the Post COVID-19 World The global market for Contract Research Outsourcing is expected to slump by -1.9% in the year 2020 and thereafter recover to reach US$ 72.1 billion by the year 2027, trailing a post COVID-19 CAGR of 7% over the analysis period 2020 through 2027. The COVID-19 crisis has thrown various challenges for the pharmaceutical & biopharmaceutical contract research outsourcing industry, while opening new avenues for growth across different domains. Contract research organizations serving pharmaceutical and vaccine companies were coerced to discontinue several studies owing to restrictions regarding movement of goods along with face-to-face interactions. These mandates affected central laboratories, clinical trial sites and timelines for completion of sponsored studies. Stringent guidelines enforced by countries prevented face-to-face meetings with clients, which delayed resolution of technical issues. The situation prompted various organizations to resort to video conferencing along with advanced technologies for addressing these issues. On the positive side, the COVID-19 pandemic drove the adoption of e-Clinical systems and offered new opportunities for pandemic-related research. The outbreak and associated changes in strategies required companies to bring their projects online and comply with high visibility and tight timelines. Various organizations implemented e-Clinical systems to avoid face-to-face interactions, enabling providers of these solutions to reap rich dividends. While the pandemic affected existing projects, it enabled the pharmaceutical & biopharmaceutical outsourcing industry to witness notable surge in R&D demand. The trend prompted companies to shift their focus and fine-tune existing operations to ensure efficiency for COVID-19-related projects. In addition, the work-from-home trend and repurposing of projects enabled various players to pay more attention to strategic activities. The pandemic has brought various changes in the CRO industry by delaying clinical trials, requiring repurposing of development pipeline and prompting companies to explore new options to connect with patients. Factors like patient disinclination to travel and local restrictions made companies to delay or stop non-essential study visits. Organizations were affected by customer-related trial delays, access and limitations to specific trial sites, and disruptions in the supply chain. The shift towards COVID-19 vaccine and treatments increased the workload for CROs. Known for their high capacity and flexibility, majority of CROs effectively accommodated the volume within a short span. Contract research organizations made concerted efforts towards accommodation of new projects without compromising over existing projects for other medical conditions or indications. The pandemic is anticipated to benefit the biopharmaceutical drug development industry and strengthen drug development activity, requiring players to efficiently use digital solutions, data insights and patient engagements. Easing of restrictions and reopening of businesses are likely to bring non-COVID-19 trials on track and drive organizations to pay more attention to decentralized clinical trial solutions including digital platforms along with mobile phlebotomists and nurses. In addition, these clinical trials are expected to reduce the requirement for patients and other participants to travel, which remains a major challenge during the current scenario. Changes in business operations for pharmaceutical companies are prompting CROs and other participants to adjust their practices. The impact of COVID-19 on face-to-face interactions with clients is driving various companies to implement new platforms for virtual connectivity. The COVID-19 healthcare emergency has created a pressing need for a collaborative approach among health authorities, pharmaceutical players, regulators and CROs for developing and producing safe and effective treatments. The holistic approach combining resources and the required expertise is expected to pave way for efficient distribution of the impending vaccine globally. CROs are partnering with pharmaceutical companies for targeting data integrity and patient safety, as well as with other stakeholders including regulators and sites for patient safety-related considerations. Players are also implementing sophisticated solutions for research sites and clinical studies to reduce the burden on healthcare providers, patients and investigational sites. CROs are anticipated to play a critical role during the pandemic by taking responsibility for consistent on-site support. MARKET TRENDS & DRIVERS
MARKET OVERVIEW
FOCUS ON SELECT PLAYERS (Total 152 Featured)
For more information about this report visit https://www.researchandmarkets.com/r/lwhcix The post Global Contract Research Outsourcing Market Report appeared first on Medical News And Updates. A COVID-19 testing station outside Mission San Luis Rey in Oceanside last year. Courtesy San Diego County San Diego County’s Health and Human Services Agency reported 686 new COVID-19 infections Sunday, no additional deaths and only a slight rise in hospitalizations. The new data increased the county’s total cases during the pandemic to 332,014. The death toll remained at 3,880. The number of hospitalized patients increased by five Sunday, while one more person required admission to intensive care. In addition, the county noted 17,208 additional COVID tests with 7.3% returning positive over the past seven days. Statewide, California reported 11,828 new cases Sunday and 104 deaths. That brings the total number of cases in the state since early 2020 to nearly 4.2 million. Deaths statewide stand at 65,243. Show comments The post County Health Officials Report 686 New COVID-19 Cases, No New Deaths appeared first on Medical News And Updates. |
AuthorMedical News Update is a leading web-based technology and business news service that focuses on all aspects inside the medical niche. ArchivesCategories |